Colorectal Cancer – Epidemiology – Emerging Markets

Clarivate Epidemiology’s coverage of colorectal carcinoma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed incidence of colorectal carcinoma for each country as well as annualized case counts projected to the national population.

In addition to forecasting diagnosed incident patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy.

Clarivate Epidemiology’s colorectal carcinoma forecast will answer the following questions:

  • How will change in the levels of exposure to known risk or protective factors affect the number of people diagnosed with colorectal carcinoma per year?
  • In developing countries, what impact will economic growth and development have on the number of people diagnosed with colorectal carcinoma per year?
  • How will improvements in survival change the number of people living with a diagnosis of colorectal carcinoma?
  • How will the decreasing recurrence risk change the number of first-line drug-treatment opportunities for colorectal carcinoma?
  • How will the epidemiology of colorectal carcinoma be impacted in the countries with colorectal carcinoma screening programs?
  • Of all people diagnosed with colorectal carcinoma, how many in each country across developed countries are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of colorectal carcinoma over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.

In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least ten years of forecast data for the following colorectal carcinoma subpopulations:

  • Diagnosed incident cases of colon carcinoma by stage at diagnosis.
  • Diagnosed incident cases of rectal carcinoma by stage at diagnosis.
  • Diagnosed prevalent cases of colon carcinoma by drug-treatment status.
  • Diagnosed prevalent cases of rectal carcinoma by drug-treatment status.
  • First-line drug-treatable colorectal carcinoma population (mutated BRAF) by treatment status.
  • First-line drug-treatable colorectal carcinoma population (mutated RAS) by treatment status.
  • First-line drug-treatable colorectal carcinoma population (wild-type RAS/BRAF) by treatment status.
  • Second-line drug-treatable colorectal carcinoma population (mutated BRAF) by treatment status.
  • Second-line drug-treatable colorectal carcinoma population (mutated RAS) by treatment status.
  • Second-line drug-treatable colorectal carcinoma population (wild-type RAS/BRAF) by treatment status.
  • … and many more (details available on request).

Note: Coverage may vary by country.

Table of contents

  • Colorectal Cancer - Epidemiology - Emerging Markets
    • Introduction
      • Incidence of Colorectal Cancer per 100,000 per Year Among People of All Ages in 2018 and 2028ttttttttt
      • Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Colorectal Cancer Over the Next 10 Yearsttttttttt
      • Number of Additional Incident Cases of Colorectal Cancer Incurred Over 2018-2028 in the Countries Under Study Due to Trends in Risk
    • Epidemiology Data
    • Methods
      • Diagnosed Incident Cases
      • Stage at Diagnosis
      • Diagnosed Prevalent Cases
      • Recurrent Incident Cases
      • Drug-Treatable Populations
      • Drug-Treated Populations
      • Lifetime DALYs Gained
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Colorectal Cancer
        • Studies Excluded from the Analysis of Colorectal Cancer
      • Risk/Protective Factors
        • Risk/Protective Factors for Colorectal Cancer
      • Bibliography